Related references
Note: Only part of the references are listed.Transcriptomics and solid tumors: The next frontier in precision cancer medicine
Apostolia M. Tsimberidou et al.
SEMINARS IN CANCER BIOLOGY (2022)
Building patient-specific models for receptor tyrosine kinase signaling networks
Kyoichi Ebata et al.
FEBS JOURNAL (2022)
The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistance
Yuesheng Zhang
PHARMACOLOGY & THERAPEUTICS (2021)
The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2021)
Personalized Genome-Scale Metabolic Models Identify Targets of Redox Metabolism in Radiation-Resistant Tumors
Joshua E. Lewis et al.
CELL SYSTEMS (2021)
An expanded universe of cancer targets
William C. Hahn et al.
CELL (2021)
Druggable genome and precision medicine in cancer: current challenges
Camille Amandine Dupont et al.
FEBS JOURNAL (2021)
Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
Bradley A. Maron et al.
NATURE COMMUNICATIONS (2021)
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
Erin F. Cobain et al.
JAMA ONCOLOGY (2021)
Building mean field ODE models using the generalized linear chain trick & Markov chain theory
Paul J. Hurtado et al.
JOURNAL OF BIOLOGICAL DYNAMICS (2021)
Investigating Molecular Determinants of Cancer Cell Resistance to Ionizing Radiation Through an Integrative Bioinformatics Approach
Halil Ibrahim Toy et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
An engineered protein-phosphorylation toggle network with implications for endogenous network discovery
Deepak Mishra et al.
SCIENCE (2021)
Precision Medicine in Oncology: A Review of Multi-Tumor Actionable Molecular Targets with an Emphasis on Non-Small Cell Lung Cancer
Matthew K. Stein et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Modeling the Nonlinear Dynamics of Intracellular Signaling Networks
Oleksii S. Rukhlenko et al.
BIO-PROTOCOL (2021)
A systematic analysis of signaling reactivation and drug resistance
Boris N. Kholodenko et al.
CELL REPORTS (2021)
A review of dynamical systems approaches for the detection of chaotic attractors in cancer networks
Abicumaran Uthamacumaran
PATTERNS (2021)
Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients
Wei-Feng Guo et al.
NUCLEIC ACIDS RESEARCH (2021)
From Tissue-Agnostic to N-of-One Therapies:(R)Evolution of the Precision Paradigm
Jacob J. Adashek et al.
TRENDS IN CANCER (2021)
A comparison of deterministic and stochastic approaches for sensitivity analysis in computational systems biology
Giulia Simoni et al.
BRIEFINGS IN BIOINFORMATICS (2020)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration
David M. Kent et al.
ANNALS OF INTERNAL MEDICINE (2020)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement
David M. Kent et al.
ANNALS OF INTERNAL MEDICINE (2020)
Network control principles for identifying personalized driver genes in cancer
Wei-Feng Guo et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Meagan B. Ryan et al.
CLINICAL CANCER RESEARCH (2020)
A systems approach to clinical oncology uses deep phenotyping to deliver personalized care
James T. Yurkovich et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The microcosmos of intratumor heterogeneity: the space-time of cancer evolution
Michalina Janiszewska
ONCOGENE (2020)
Statistical Methods in Precision Oncology
Ying Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Personalized signaling models for personalized treatments
Julio Saez-Rodriguez et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Uncovering axes of variation among single-cell cancer specimens
William S. Chen et al.
NATURE METHODS (2020)
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
Elias Jabbour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
How Machine Learning Will Transform Biomedicine
Jeremy Goecks et al.
CELL (2020)
Fifteen Years of Gene Set Analysis for High-Throughput Genomic Data: A Review of Statistical Approaches and Future Challenges
Samarendra Das et al.
ENTROPY (2020)
Context specificity of the EMT transcriptional response
David P. Cook et al.
NATURE COMMUNICATIONS (2020)
Applications of personalised signalling network models in precision oncology
Jordan F. Hastings et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Extrinsic Noise and Heavy-Tailed Laws in Gene Expression
Lucy Ham et al.
PHYSICAL REVIEW LETTERS (2020)
Review of precision cancer medicine: Evolution of the treatment paradigm
Apostolia M. Tsimberidou et al.
CANCER TREATMENT REVIEWS (2020)
Periodic propagating waves coordinate RhoGTPase network dynamics at the leading and trailing edges during cell migration
Alfonso Bolado-Carrancio et al.
ELIFE (2020)
Machine learning approaches to drug response prediction: challenges and recent progress
George Adam et al.
NPJ PRECISION ONCOLOGY (2020)
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S. Grasso et al.
CANCER CELL (2020)
Patient-specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies (vol 16, e8664, 2020)
Federica Eduati et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
Keith T. Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition
Wei He et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2020)
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
Nicholas C Turner et al.
LANCET ONCOLOGY (2020)
Modelling of Immune Checkpoint Network Explains Synergistic Effects of Combined Immune Checkpoint Inhibitor Therapy and the Impact of Cytokines in Patient Response
Maria Kondratova et al.
CANCERS (2020)
A survey of gene regulatory networks modelling methods: from differential equations, to Boolean and qualitative bioinspired models
Roberto Barbuti et al.
JOURNAL OF MEMBRANE COMPUTING (2020)
Machine Learning in Oncology: What Should Clinicians Know?
Matthew Nagy et al.
JCO CLINICAL CANCER INFORMATICS (2020)
Executable cancer models: successes and challenges
Matthew A. Clarke et al.
NATURE REVIEWS CANCER (2020)
Spatial Stochastic Intracellular Kinetics: A Review of Modelling Approaches
Stephen Smith et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2019)
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer
Tsz-Lun Yeung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling
Keesha E. Erickson et al.
SEMINARS IN CANCER BIOLOGY (2019)
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer
Tsz-Lun Yeung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Ayesha Murtuza et al.
CANCER RESEARCH (2019)
Modeling the dynamic behavior of biochemical regulatory networks
John J. Tyson et al.
JOURNAL OF THEORETICAL BIOLOGY (2019)
Targeting Alterations in the RAF-MEK Pathway
Rona Yaeger et al.
CANCER DISCOVERY (2019)
Personalization of Logical Models With Multi-Omics Data Allows Clinical Stratification of Patients
Jonas Beal et al.
FRONTIERS IN PHYSIOLOGY (2019)
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K. Sicklick et al.
NATURE MEDICINE (2019)
Stochastic simulation algorithms for computational systems biology: Exact, approximate, and hybrid methods
Giulia Simoni et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2019)
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
Alessandro Leonetti et al.
BRITISH JOURNAL OF CANCER (2019)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Adaptive platform trials: definition, design, conduct and reporting considerations The Adaptive Platform Trials Coalition
Derek C. Angus et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
Federica Miglietta et al.
ONCOLOGIST (2019)
Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
Martin Sjostrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Why geneticists stole cancer research even though cancer is primarily a signaling disease
Michael B. Yaffe
SCIENCE SIGNALING (2019)
Modeling cell line-specific recruitment of signaling proteins to the insulin-like growth factor 1 receptor
Keesha E. Erickson et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
Hyojin Kim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2019)
Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why
Angelique Stephanou et al.
ACTA BIOTHEORETICA (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update
Gregory P. Kalemkerian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors
Wagner Ricardo Montor et al.
MOLECULAR CANCER (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling
Oleksii S. Rukhlenko et al.
CELL SYSTEMS (2018)
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial
Reinhard Dummer et al.
LANCET ONCOLOGY (2018)
Integrative omics analyses broaden treatment targets in human cancer
Sohini Sengupta et al.
GENOME MEDICINE (2018)
Transition state characteristics during cell differentiation
Rowan D. Brackston et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Systems biology primer: the basic methods and approaches
Iman Tavassoly et al.
SYSTEMS BIOLOGY (2018)
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
David M. Kent et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL
Julia D. Wulfkuhle et al.
JCO PRECISION ONCOLOGY (2018)
Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis
Naoki Niikura et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L. R. Yates et al.
ANNALS OF ONCOLOGY (2018)
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial
W. Shi et al.
ANNALS OF ONCOLOGY (2017)
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial
Antonio Llombart-Cussac et al.
LANCET ONCOLOGY (2017)
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Relaxation oscillations and hierarchy of feedbacks in MAPK signaling
Marek Kochanczyk et al.
SCIENTIFIC REPORTS (2017)
Potential landscape of high dimensional nonlinear stochastic dynamics with large noise
Ying Tang et al.
SCIENTIFIC REPORTS (2017)
Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type-Specific Dynamic Logic Models
Federica Eduati et al.
CANCER RESEARCH (2017)
Precision medicine driven by cancer systems biology
Fabian V. Filipp
CANCER AND METASTASIS REVIEWS (2017)
Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Miranta Antoniou et al.
JOURNAL OF PERSONALIZED MEDICINE (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Negative feedback regulation of the ERK1/2 MAPK pathway
David Lake et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mechanical bounds to transcriptional noise
Stuart A. Sevier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The cancer immunogram
Christian U. Blank et al.
SCIENCE (2016)
Integrating network reconstruction with mechanistic modeling to predict cancer therapies
Melinda Halasz et al.
Science Signaling (2016)
Integrating network reconstruction with mechanistic modeling to predict cancer therapies
Melinda Halasz et al.
Science Signaling (2016)
Flipping the Rac-Rho Switch in Cell Motility
Leah Edelstein-Keshet
CELL SYSTEMS (2016)
A Comparison of Deterministic and Stochastic Modeling Approaches for Biochemical Reaction Systems: On Fixed Points, Means, and Modes
Sayuri K. Hahl et al.
FRONTIERS IN GENETICS (2016)
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Miranta Antoniou et al.
PLOS ONE (2016)
Long term HER2+metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA
J. -P. Spano et al.
BREAST (2015)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
Quantitative and logic modelling of molecular and gene networks
Nicolas Le Novere
NATURE REVIEWS GENETICS (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Sandra M. Swain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey et al.
SCIENCE SIGNALING (2015)
Drug Resistance Resulting from Kinase Dimerization Is Rationalized by Thermodynamic Factors Describing Allosteric Inhibitor Effects
Boris N. Kholodenko
CELL REPORTS (2015)
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey et al.
SCIENCE SIGNALING (2015)
Personalized Kinetic Models for Predictive Healthcare
Anupam Chowdhury et al.
CELL SYSTEMS (2015)
Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and Pharmacodynamics
Aarash Bordbar et al.
CELL SYSTEMS (2015)
Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
W. Du et al.
ONCOGENE (2015)
The dynamic control of signal transduction networks in cancer cells
Walter Kolch et al.
NATURE REVIEWS CANCER (2015)
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
F. Ciardiello et al.
ANNALS OF ONCOLOGY (2014)
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry
Isabell Witzel et al.
BMC CANCER (2014)
Inference of dynamic networks using time-course data
Yongsoo Kim et al.
BRIEFINGS IN BIOINFORMATICS (2014)
Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches?
Heinrich J. Huber et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Reverse engineering and identification in systems biology: strategies, perspectives and challenges
Alejandro F. Villaverde et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
Mathematical models of the transitions between endocrine therapy responsive and resistant states in breast cancer
Chun Chen et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
Fabrice Andre et al.
LANCET ONCOLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
A framework for parameter estimation and model selection from experimental data in systems biology using approximate Bayesian computation
Juliane Liepe et al.
NATURE PROTOCOLS (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Construction of an Effective Landscape for Multistate Genetic Switches
Mingyang Lu et al.
PHYSICAL REVIEW LETTERS (2014)
ESSAY Evidence based medicine: a movement in crisis?
Trisha Greenhalgh et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Principles and methods of integrative genomic analyses in cancer
Vessela N. Kristensen et al.
NATURE REVIEWS CANCER (2014)
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
H. Raza Ali et al.
GENOME BIOLOGY (2014)
Integrating Bayesian variable selection with Modular Response Analysis to infer biochemical network topology
Tapesh Santra et al.
BMC SYSTEMS BIOLOGY (2013)
Systems Analysis of BCL2 Protein Family Interactions Establishes a Model to Predict Responses to Chemotherapy
Andreas U. Lindner et al.
CANCER RESEARCH (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Tumor adaptation and resistance to RAF inhibitors
Piro Lito et al.
NATURE MEDICINE (2013)
Systematic Construction of Kinetic Models from Genome-Scale Metabolic Networks
Natalie J. Stanford et al.
PLOS ONE (2013)
Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines
Mario Niepel et al.
SCIENCE SIGNALING (2013)
Relief of Feedback Inhibition of HER3 Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in BRAF-Mutant Thyroid Carcinomas
Cristina Montero-Conde et al.
CANCER DISCOVERY (2013)
Perturbation Biology: Inferring Signaling Networks in Cellular Systems
Evan J. Molinelli et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
TIGRESS: Trustful Inference of Gene REgulation using Stability Selection
Anne-Claire Haury et al.
BMC SYSTEMS BIOLOGY (2012)
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
Piro Lito et al.
CANCER CELL (2012)
Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy
Suzanne Hector et al.
GUT (2012)
Logic-based models in systems biology: network analysis method
Michelle L. Wynn et al.
INTEGRATIVE BIOLOGY (2012)
Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
Kimberly L. Blackwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Leveraging models of cell regulation and GWAS data in integrative network-based association studies
Andrea Califano et al.
NATURE GENETICS (2012)
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Elliott Antman et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Efficient modeling, simulation and coarse-graining of biological complexity with NFsim
Michael W. Sneddon et al.
NATURE METHODS (2011)
Predictive, personalized, preventive, participatory (P4) cancer medicine
Leroy Hood et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Elizabeth O. Lillie et al.
PERSONALIZED MEDICINE (2011)
Logic-Based Models for the Analysis of Cell Signaling Networks
Melody K. Morris et al.
BIOCHEMISTRY (2010)
Dissecting Variability in Responses to Cancer Chemotherapy Through Systems Pharmacology
R. Yang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Classic and contemporary approaches to modeling biochemical reactions
William W. Chen et al.
GENES & DEVELOPMENT (2010)
What is flux balance analysis?
Jeffrey D. Orth et al.
NATURE BIOTECHNOLOGY (2010)
Signalling ballet in space and time
Boris N. Kholodenko et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
Walter Kolch et al.
NATURE REVIEWS CANCER (2010)
Spatially distributed cell signalling
Boris N. Kholodenko
FEBS LETTERS (2009)
Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction
Julio Saez-Rodriguez et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
A dimerization-dependent mechanism drives RAF catalytic activation
Thanashan Rajakulendran et al.
NATURE (2009)
Coordination of Rho GTPase activities during cell protrusion
Matthias Machacek et al.
NATURE (2009)
Stochastic modelling for quantitative description of heterogeneous biological systems
Darren J. Wilkinson
NATURE REVIEWS GENETICS (2009)
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
Grazia Arpino et al.
ENDOCRINE REVIEWS (2008)
Domain-oriented reduction of rule-based network models
N. M. Borisov et al.
IET SYSTEMS BIOLOGY (2008)
A bistable Rb-E2F switch underlies the restriction point
Guang Yao et al.
NATURE CELL BIOLOGY (2008)
Modelling and analysis of gene regulatory networks
Guy Karlebach et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Mammalian Rho GTPases:: new insights into their functions from in vivo studies
Sarah J. Heasman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Protein networking: insights into global functional organization of proteomes
Enrico Pieroni et al.
PROTEOMICS (2008)
The properties of high-dimensional data spaces: implications for exploring gene and protein expression data
Robert Clarke et al.
NATURE REVIEWS CANCER (2008)
Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation
Takeshi Nagashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Stochastic simulation of chemical kinetics
Daniel T. Gillespie
ANNUAL REVIEW OF PHYSICAL CHEMISTRY (2007)
Data-driven modelling of signal-transduction networks
Kevin A. Janes et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Linking data to models: data regression
Khuloud Jaqaman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein
Markus Rehm et al.
EMBO JOURNAL (2006)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Cell-signalling dynamics in time and space
BN Kholodenko
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Complex networks and simple models in biology
E de Silva et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2005)
Reverse engineering of regulatory networks in human B cells
K Basso et al.
NATURE GENETICS (2005)
Opinon - Cancer as a robust system: implications for anticancer therapy
H Kitano
NATURE REVIEWS CANCER (2004)
Inferring cellular networks using probabilistic graphical models
N Friedman
SCIENCE (2004)
Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades
NI Markevich et al.
JOURNAL OF CELL BIOLOGY (2004)
Robustness of cellular functions
J Stelling et al.
CELL (2004)
BioNetGen: software for rule-based modeling of signal transduction based on the interactions of molecular domains
ML Blinov et al.
BIOINFORMATICS (2004)
A positive-feedback-based bistable 'memory module' that governs a cell fate decision
W Xiong et al.
NATURE (2003)
Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2
JR Pomerening et al.
NATURE CELL BIOLOGY (2003)
Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts
W Sha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Untangling the wires: A strategy to trace functional interactions in signaling and gene networks
BN Kholodenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades
BN Kholodenko
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
